Prenatal Screening PRISCA II (from 14 + 3 days to 22 weeks of pregnancy) | For Down Syndrome and Trisomy 18 and Neural Tube Defect

Non-invasive blood test for pregnant women, during which the concentration values of several biochemical markers and other data of the pregnant woman are used by computer programs to assess the risk of fetal chromosomal diseases or other malformations.

In the second trimester of pregnancy, the risk of the baby being born with: Down and Edwards syndromes, neural tube defect is assessed.

We inform you that before performing this test, an ultrasound examination must be performed in the same week.